saxenda glp 1 Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
![saxenda glp 1 Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://cdn.sanity.io/images/0vv8moc6/drugtopics/95e97d281e5924cde2da30014f9dab359d32abfa-7200x3600.jpg)
![saxenda glp 1 Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://nextmedasia.com/wp-content/uploads/2022/09/658193628452b03b67b2ed48_Saxenda_product-853x1024-1.jpg)
![saxenda glp 1 Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://cdn.shopify.com/s/files/1/0572/0519/4786/products/saxenda-5-pen-pack-832426_480x480.jpg?v=1664644195)
![saxenda glp 1 Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves First Generic GLP-1](https://www.senovatech.com/cn/uploads/ueditor/20240903/25d7e1f1876c7fedc1bacde60ccc67af.png)
























